| A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients (NCT00001089) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 1592U89 in HIV-Infected Adults (NCT00002200) | Glaxo Wellcome | |
| A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients (NCT00002435) | Pharmacia | |
| A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC) (NCT00001008) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) (NCT00000968) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome (NCT00000737) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Peldesine (BCX-34) in HIV-Infected Patients (NCT00002237) | BioCryst Pharmaceuticals | |
| Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn) (NCT00000630) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA (NCT00000840) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum. (NCT00000866) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia (NCT00002007) | Sandoz | |
| A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women (NCT00000897) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load (NCT00013663) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women. (NCT00000855) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study) (NCT00001020) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study (NCT00002146) | Astra USA | |
| Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS (NCT00000646) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months (NCT00000841) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs (NCT00002206) | Gilead Sciences | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex (NCT00002004) | Genentech, Inc. | |
| A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC (NCT00002155) | Merck Sharp & Dohme LLC | |
| Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection (NCT00002078) | Purdue Frederick | |
| An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects (NCT00002260) | Lederle Laboratories | |
| A Study of Megestrol Acetate in HIV-Infected Children (NCT00002182) | Gamma Project - ACTU | |
| A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus (NCT00002095) | Hoffmann-La Roche | |
| Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma (NCT00000695) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients (NCT00000907) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir (NCT00000892) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine (NCT00000963) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients (NCT00002289) | Immunobiology Research Institute | |
| The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms (NCT00000990) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors (NCT00002213) | Glaxo Wellcome | |
| Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort (NCT00662077) | Germans Trias i Pujol Hospital | |
| A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine) (NCT00000775) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Acupuncture and Herbal Treatment of Chronic HIV Sinusitis (NCT00002149) | Immune Enhancement Project | |
| A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3 (NCT00000755) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of Itraconazole in Patients With Advanced HIV Infection (NCT00002370) | Janssen, LP | |
| Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients (NCT00002041) | Bristol-Myers Squibb | |
| The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes (NCT00002356) | Ionis Pharmaceuticals, Inc. | |
| Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection (NCT00002051) | Immunobiology Research Institute | |
| A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV (NCT00002358) | Bristol-Myers Squibb | |
| Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002076) | Pfizer | |
| (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC (NCT00000679) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients (NCT00002062) | Rhone-Poulenc Rorer | |
| The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT (NCT00002302) | Ortho Pharmaceuticals | |
| Three Month Course of Anti-HIV Medications for People Recently Infected With HIV (NCT00087464) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B (NCT00002306) | Pfizer | |
| A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease (NCT00002058) | University of California, San Francisco | |
| A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3 (NCT00002129) | Otsuka America Pharmaceutical | |
| Rapid HIV Tests for Women Late in Pregnancy and During Labor (NCT00046436) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) (NCT04233047) | ViiV Healthcare | |
| Treatment Program for Anemia in AIDS Patients (NCT00002022) | R W Johnson Pharmaceutical Research Institute | |
| A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS (NCT00001995) | Pharmacia | |
| Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells. (NCT00000830) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children (NCT00000865) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy (NCT00000807) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection (NCT00000663) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Preventing Frequent Sinus Infections in HIV-Infected Patients (NCT00000752) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura (NCT00002250) | Genentech, Inc. | |
| HIV-discordant Couple Intrauterine Insemination (NCT00975546) | University of Missouri-Columbia | |
| Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV (NCT00027339) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women (NCT00000744) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine (NCT00000732) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush (NCT00000951) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment of Chronic Cryptosporidiosis in AIDS Patients (NCT00001128) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Blood Test to Look at Cells of the Immune System in Healthy Children (NCT00001109) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. (NCT00002132) | Janssen Pharmaceuticals | |
| Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo) (NCT00002063) | Glaxo Wellcome | |
| Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS (NCT00000693) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Azidothymidine in HIV-Infected Children (NCT00000982) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS (NCT00000966) | Pfizer | |
| A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex (NCT00000988) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Viracept Expanded Access Program (NCT00002165) | Agouron Pharmaceuticals | |
| Study of Enfuvirtide in HIV-Positive Subjects (NCT00086710) | Trimeris | |
| A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC) (NCT00002060) | Newport Pharmaceuticals International | |
| A Study of BufferGel in Women (NCT00000927) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment (NCT00005931) | SUGEN | |
| A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection (NCT00002119) | Oxo Chemie GmbH | |
| An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects (NCT00002271) | Lederle Laboratories | |
| A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly (NCT00001122) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of MDL 28,574A in HIV-Infected Patients (NCT00002329) | Hoechst Marion Roussel | |
| Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection (NCT00000875) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B) (NCT00000767) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects (NCT00000798) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment (NCT00002216) | Glaxo Wellcome | |
| The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS (NCT00001024) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs (NCT00021554) | Hoffmann-La Roche | |
| Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV (NCT00122512) | FHI 360 | |
| A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs (NCT00002308) | Bristol-Myers Squibb | |
| Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy (NCT00005779) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults (NCT00013572) | Walter Reed Army Institute of Research (WRAIR) | |
| A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma (NCT00002212) | Ligand Pharmaceuticals | |
| Recovery Management Intervention in China (NCT01270100) | University of California, Los Angeles | |
| Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV (NCT00002104) | Aaron Diamond AIDS Research Center | |
| A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers (NCT00000884) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea (NCT00000980) | Rhone-Poulenc Rorer | |
| A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases (NCT00002044) | Glaxo Wellcome | |
| An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) (NCT00002090) | Pfizer | |
| HIV Prevention Preparedness Study (NCT00048282) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis (NCT00000816) | National Institute of Allergy and Infectious Diseases (NIAID) | |